Company: : Cambridge Major Laboratories, Inc. (CML)
Description: CML is a global leader in API development and manufacturing to the pharmaceutical and biotechnology industries. CML produces pharmaceutical intermediates and API’s from preclinical through commercial manufacture. Operating across three facilities in the U.S. and Europe, CML services include process chemistry, API manufacturing, analytical sciences, solid state chemistry and quality assurance.
Website: www.c-mlabs.com
Booth Number: 50C52
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.